furosemide and bix 01294

furosemide has been researched along with bix 01294 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ	1
Amendola, G; Castellano, S; Cheng, X; Cipriano, A; Cosconati, S; Feoli, A; Horton, JR; Milite, C; Novellino, E; Pepe, G; Pisapia, V; Rescigno, D; Sbardella, G; Viviano, M	1

Other Studies

2 other study(ies) available for furosemide and bix 01294

Article	Year
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15 Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship	2013
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure. Journal of medicinal chemistry, 2019, 03-14, Volume: 62, Issue:5 Topics: Blood-Brain Barrier; Cell Line, Tumor; Cell Membrane Permeability; Crystallography, X-Ray; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Histone-Lysine N-Methyltransferase; Humans; Molecular Structure; Structure-Activity Relationship	2019

Article

Year

Identification of potent Yes1 kinase inhibitors using a library screening approach.

Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013

Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure.

Journal of medicinal chemistry, 2019, 03-14, Volume: 62, Issue:5

Topics: Blood-Brain Barrier; Cell Line, Tumor; Cell Membrane Permeability; Crystallography, X-Ray; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Histone-Lysine N-Methyltransferase; Humans; Molecular Structure; Structure-Activity Relationship

2019